Spots Global Cancer Trial Database for stereotactic body radiation therapy
Every month we try and update this database with for stereotactic body radiation therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Evaluation of Stereotactic Body Radiotherapy as a Bridge Therapy for Hepatocellular Carcinoma Patients Enlisted for Liver Transplantation | NCT06218420 | Hepatocellular ... | Stereotactic Bo... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma | NCT04945642 | Prostate Adenoc... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IVA Prost... | High-Dose Rate ... Stereotactic Bo... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| SBRT Plus vNKT for Pancreatic Cancer | NCT05783076 | Pancreatic Canc... | Stereotactic bo... adoptive cell t... | 18 Years - | Changhai Hospital | |
| Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer | NCT03812289 | Hepatocellular ... | Quality-of-Life... Questionnaire A... Stereotactic Bo... | 18 Years - | OHSU Knight Cancer Institute | |
| Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma | NCT03712904 | Uveal Melanoma | Stereotactic Bo... Ziv-Aflibercept | 18 Years - | Thomas Jefferson University | |
| Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer | NCT01730937 | Adult Primary H... Advanced Adult ... Recurrent Adult... | Sorafenib stereotactic bo... | 18 Years - | Radiation Therapy Oncology Group | |
| Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer | NCT03796767 | Recurrent Prost... Metastatic Mali... Metastatic Mali... Oligometastasis Prostate Adenoc... PSA Failure | Hypofractionate... Intensity-Modul... Metastasectomy Quality-of-Life... Questionnaire A... Stereotactic Bo... | 18 Years - | University of Utah | |
| A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely | NCT03175146 | Colonic Neoplas... Neoplasm Metast... | Stereotactic Bo... | 18 Years - 80 Years | AHS Cancer Control Alberta | |
| Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) With Osimertinib for the Treatment of Patients With Oligoprogressive EGFR Positive Non-small Cell Lung Carcinoma | NCT06014827 | Lung Non-Small ... Stage IV Lung C... | Biospecimen Col... Computed Tomogr... Osimertinib Positron Emissi... Stereotactic Bo... Survey Administ... | 18 Years - | City of Hope Medical Center | |
| Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging | NCT06276465 | Prostatic Cance... | Darolutamide 30... Stereotactic bo... Androgen depriv... | 18 Years - | UNICANCER | |
| Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma | NCT04974671 | Renal Cell Carc... Metastatic Rena... Oligoprogressiv... Progression | Stereotactic Bo... | 18 Years - | Yale University | |
| Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON) | NCT04569461 | Prostate Cancer | pembrolizumab Stereotactic bo... Short-term andr... Radical Prostat... | 18 Years - | Duke University | |
| Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC | NCT04786093 | Non Small Cell ... | Stereotactic ra... Durvalumab | 18 Years - | University of Texas Southwestern Medical Center | |
| Post SBRT Pulmonary Metastasectomy (PSPM) Trial | NCT04160143 | Surgical Resect... Stereotactic Bo... Lung Cancer Pulmonary Metas... | Surgical resect... | 18 Years - | McMaster University | |
| Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer | NCT01959672 | Pancreatic Aden... Resectable Panc... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | 4-Dimensional C... Fluorouracil Gemcitabine Hyd... Laboratory Biom... Leucovorin Calc... Nelfinavir Mesy... Oregovomab Stereotactic Bo... Therapeutic Con... | 19 Years - | University of Nebraska | |
| Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy | NCT04915508 | Prostate Adenoc... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Hormone Therapy Stereotactic Bo... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung | NCT00832780 | Lung Cancer Non Small Cell ... Solid Tumors | Stereotactic Bo... | 18 Years - | New Mexico Cancer Care Alliance | |
| Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma | NCT03304639 | Advanced Merkel... Clinical Stage ... Clinical Stage ... Metastatic Merk... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... | Pembrolizumab Stereotactic Bo... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular Carcinoma | NCT02513199 | Hepatocellular ... | SBRT TACE | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma | NCT03253536 | Hepatocellular ... Quality of Life Stereotactic Bo... Observational | observational | 18 Years - | Ludwig-Maximilians - University of Munich | |
| Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer | NCT00087438 | Lung Cancer | stereotactic bo... | 18 Years - | Radiation Therapy Oncology Group | |
| Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer | NCT04073745 | Lung Non-Small ... Positive Surgic... Resected Mass Stage III Lung ... Stage IIIA Lung... Stage IIIB Lung... Stage IIIC Lung... Stage IV Lung C... Stage IVA Lung ... Stage IVB Lung ... | Quality-of-Life... Questionnaire A... Stereotactic Bo... | 18 Years - | Roswell Park Cancer Institute | |
| The ctDNA for Evaluating Whether to Use Adjuvant Therapy After SBRT in Patients With Early Lung Cancer | NCT05411809 | Stereotactic Bo... | drug adjuvant t... | 18 Years - 80 Years | Peking University Third Hospital | |
| Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma | NCT03253536 | Hepatocellular ... Quality of Life Stereotactic Bo... Observational | observational | 18 Years - | Ludwig-Maximilians - University of Munich | |
| Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy | NCT02710253 | Hematopoietic a... Metastatic Mali... | External Beam R... Laboratory Biom... Stereotactic Bo... | 18 Years - | M.D. Anderson Cancer Center | |
| SBRT Plus Pembrolizumab and Trametinib for Pancreatic Cancer | NCT02704156 | Pancreatic Canc... | Cyberknife plus... Cyberknife plus... | 18 Years - | Changhai Hospital | |
| Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | NCT00777894 | Liver Cancer | 3-dimensional c... intensity-modul... stereotactic bo... | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer | NCT03110978 | Lung Atypical C... Lung Neuroendoc... Lung Non-Small ... Minimally Invas... Neuroendocrine ... Recurrent Lung ... Recurrent Lung ... Recurrent Lung ... Stage I Lung Ca... Stage IA1 Lung ... Stage IA2 Lung ... Stage IA3 Lung ... Stage IB Lung C... Stage IIA Lung ... | Nivolumab Stereotactic Bo... | 18 Years - | M.D. Anderson Cancer Center | |
| A Proof of Principle Study of Pembrolizumab With SBRT in TKI mRCC Patients | NCT02599779 | Stage IV Renal ... | Pembrolizumab Stereotactic Bo... | 18 Years - | Sunnybrook Health Sciences Centre | |
| Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic Cancer | NCT02704143 | Pancreatic Canc... | combination of ... | 18 Years - | Changhai Hospital | |
| ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer | NCT03294889 | Prostate Cancer | Stereotactic bo... | 18 Years - 85 Years | University Hospital, Geneva | |
| Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer | NCT05241340 | Urothelial Carc... | Sasanlimab Stereotactic Bo... Radical Cystect... | 18 Years - | The Methodist Hospital Research Institute | |
| Non-interventional Observational Study of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Cancer | NCT02228356 | Neoplasm Metast... | Stereotactic Bo... | 18 Years - 100 Years | Universitair Ziekenhuis Brussel | |
| Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT01345851 | Adenocarcinoma ... Adenosquamous C... Large Cell Lung... Recurrent Non-s... Squamous Cell L... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... Stage IIIB Non-... | hypofractionate... laboratory biom... image-guided ra... carboplatin paclitaxel stereotactic bo... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer | NCT02128100 | Pancreatic Canc... | Folfirinox Stereotactic Bo... | 18 Years - | University of Louisville | |
| Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients | NCT03812549 | Stage IV NSCLC | Sintilimab stereotactic bo... Low Dose Radiot... | 18 Years - 70 Years | Sichuan University | |
| A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer | NCT04997018 | Prostate Cancer | Radiation Thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Phase II Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Treating Patients With Stage IV Melanoma | NCT01970527 | Recurrent Melan... Stage IV Skin M... | Ipilimumab Laboratory Biom... Pharmacological... Stereotactic Bo... | 18 Years - | University of Washington | |
| Safety and Preliminary Efficacy of SBRT in Patients With Metastatic RCC Treated With Targeted or IO Therapy | NCT02864615 | Metastatic Rena... | SBRT | 18 Years - 75 Years | Kidney Cancer Research Bureau | |
| Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer | NCT01185639 | Non-Small-Cell ... Liver Cancer Adrenal Cancer | stereotactic bo... | 18 Years - 90 Years | Wake Forest University Health Sciences | |
| Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma | NCT06211335 | Locally Recurre... Metastatic Head... Refractory Head... | Losartan Pembrolizumab Stereotactic Bo... | 18 Years - | University of California, Davis | |
| Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Metastatic Triple Negative Breast Cancer | NCT03151447 | Metastatic Brea... | stereotactic bo... | 18 Years - 75 Years | Fudan University | |
| SBRT in Early Breast Cancer in Elderly Women | NCT05071105 | Breast Neoplasm... | Stereotactic Bo... | 75 Years - | University of Rome Tor Vergata | |
| SRS Study in Patients With Non-Small Cell Lung Cancer | NCT00489008 | Lung Cancer | Stereotactic Bo... | - | M.D. Anderson Cancer Center | |
| Testing the Addition of Radiation Therapy to Immunotherapy for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 Negative | NCT04929041 | Lung Adenocarci... Lung Adenosquam... Lung Non-Small ... Stage IIIB Lung... Stage IIIC Lung... Stage IV Lung C... | Biopsy Biospecimen Col... Computed Tomogr... Echocardiograph... Ipilimumab Magnetic Resona... Nivolumab Positron Emissi... Quality-of-Life... Stereotactic Bo... | 18 Years - | National Cancer Institute (NCI) | |
| PRORAD-5 PROstate RADiation in 5 Fractions: Phase Ib Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer | NCT06369246 | Advanced Prosta... | Stereotactic Bo... | 18 Years - | M.D. Anderson Cancer Center | |
| Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II Trial | NCT02045446 | Stage IV Non-Sm... | Stereotactic Bo... Maintenance che... | 18 Years - 99 Years | University of Texas Southwestern Medical Center | |
| Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers | NCT05379972 | Gastric Cancer GastroEsophagea... | Pembrolizumab Olaparib Stereotactic Bo... | 18 Years - 100 Years | University of Colorado, Denver | |
| Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC. | NCT05615142 | NSCLC Low Dose Radiot... Stereotactic Bo... PD-1 Inhibitor | Low Dose Radiot... stereotactic bo... PD-1 Inhibitors | 18 Years - | Sichuan University | |
| Stereotactic Body Radiation Therapy in Liver Cancer That Cannot be Removed by Surgery or Transplant | NCT01194206 | Adult Primary H... Advanced Adult ... Localized Unres... Recurrent Adult... | stereotactic bo... | 18 Years - 70 Years | Case Comprehensive Cancer Center | |
| Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery | NCT00833859 | Pancreatic Neop... | GTX (gemcitabin... stereotactic bo... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Bintrafusp Alfa and Stereotactic Body Radiation Therapy for the Treatment of Recurrent or Second Primary Head and Neck Squamous Cell Cancer | NCT04220775 | Recurrent Head ... Second Primary ... | Bintrafusp Alfa Quality-of-Life... Questionnaire A... Stereotactic Bo... | 18 Years - | M.D. Anderson Cancer Center | |
| Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer | NCT03361735 | Prostate Adenoc... | Leuprolide Acet... Goserelin Aceta... Stereotactic Bo... Radium Ra 223 D... Laboratory Biom... Degarelix | 18 Years - | City of Hope Medical Center | |
| Stereotactic Ablative Radiation Therapy for Prostate Cancer | NCT05668351 | Prostate Cancer | SUPR-SABR treat... | 18 Years - | Medical University of South Carolina | |
| ACTInium-J591 Radionuclide Therapy in PSMA-Detected Metastatic HOrmone-Sensitive Recurrent Prostate CaNcer | NCT05567770 | Prostate Cancer... | Actinium-J591 Stereotactic Bo... Androgen Depriv... | 18 Years - 90 Years | Weill Medical College of Cornell University | |
| Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors | NCT00837928 | Metastatic Canc... Unspecified Adu... | bendamustine laboratory biom... Surgical Resect... Stereotactic bo... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Radiofrequency Ablation Versus Stereotactic Radiotherapy in Colorectal Liver Metastases | NCT01233544 | Colorectal Carc... Liver Metastase... | SBRT or RFA | 18 Years - 90 Years | University of Aarhus | |
| Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors | NCT00837928 | Metastatic Canc... Unspecified Adu... | bendamustine laboratory biom... Surgical Resect... Stereotactic bo... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Additional Treatment for Isolated Local Pancreatic Cancer Recurrence Using Stereotactic Body Radiation Therapy | NCT04881487 | Recurrent Pancr... | Additional ster... | 18 Years - | UMC Utrecht | |
| Surgery Versus Stereotactic Body Radiation Therapy for Stage up to IA2 (T1a or T1b) Non-small Cell Lung Cancer | NCT03431415 | Non-small Cell ... Surgery Stereotactic Bo... | Anatomical Segm... Stereotactic Bo... | 18 Years - 75 Years | Institut universitaire de cardiologie et de pneumologie de Québec, University Laval | |
| QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy | NCT03169764 | Head and Neck S... | Avelumab Bevacizumab Capecitabine Cetuximab Cisplatin cyclophosphamid... 5-Fluorouracil ... fulvestrant leucovorin nab-paclitaxel nivolumab Lovaza Stereotactic Bo... ALT-803 ETBX-011 ETBX-021 ETBX-051 ETBX-061 GI-4000 GI-6207 GI-6301 haNK | 18 Years - | ImmunityBio, Inc. | |
| Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer | NCT00087438 | Lung Cancer | stereotactic bo... | 18 Years - | Radiation Therapy Oncology Group | |
| A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403) | NCT00238875 | T1N0M0 Non-smal... | stereotactic bo... | 20 Years - | Japan Clinical Oncology Group | |
| Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery | NCT00738868 | Head and Neck C... | cetuximab stereotactic bo... | 18 Years - | National Cancer Institute (NCI) | |
| Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma | NCT03704662 | Pancreatic Canc... | Stereotactic Bo... Preoperative Fr... | 18 Years - | Medical College of Wisconsin | |
| MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK Trial | NCT04580836 | Renal Cell Carc... Stage I Renal C... Stage II Renal ... | Magnetic Resona... Questionnaire A... Stereotactic Bo... | 18 Years - | M.D. Anderson Cancer Center | |
| Cyberknife® Partial Breast Irradiation (PBI) for Early Stage Breast Cancer | NCT01162200 | Early Stage Bre... | Stereotactic Bo... | 18 Years - 99 Years | University of Texas Southwestern Medical Center | |
| Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer | NCT06130826 | Breast Carcinom... Colorectal Carc... | Biopsy Biospecimen Col... Bone Scan Computed Tomogr... Immunotherapy Magnetic Resona... Positron Emissi... Stereotactic Bo... | 18 Years - | City of Hope Medical Center | |
| Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer | NCT00607828 | Liver Cancer | stereotactic bo... | 19 Years - 120 Years | University of Nebraska | |
| Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer | NCT00891904 | Head and Neck C... | cetuximab stereotactic bo... | 18 Years - 120 Years | Roswell Park Cancer Institute | |
| Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases With Perilesional Edema in NSCLC | NCT04147728 | Stereotactic Bo... | Anlotinib Stereotactic Ra... | 18 Years - 80 Years | Peking University Third Hospital | |
| Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC) | NCT01799135 | Non Small Cell ... | DCE-MRI scan Stereotactic Bo... 4D-CT scan | 18 Years - | Dana-Farber Cancer Institute | |
| A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer | NCT02307474 | Clear Cell Rena... Renal Cell Carc... | Stereotactic Ra... Pazopanib Hydro... | 18 Years - | Case Comprehensive Cancer Center | |
| Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery | NCT02830165 | Stage I Prostat... Stage II Prosta... Stage III Prost... | Laboratory Biom... Quality-of-Life... Stereotactic Bo... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK Trial | NCT04580836 | Renal Cell Carc... Stage I Renal C... Stage II Renal ... | Magnetic Resona... Questionnaire A... Stereotactic Bo... | 18 Years - | M.D. Anderson Cancer Center | |
| Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery | NCT03541850 | PSA Level Great... PSA Progression Stage I Prostat... Stage II Prosta... Stage III Prost... | Antiandrogen Th... Quality-of-Life... Stereotactic Bo... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell Cancer | NCT04834349 | Recurrent Head ... Unresectable He... | Hafnium Oxide-c... Intensity-Modul... Intensity-Modul... Pembrolizumab Quality-of-Life... Questionnaire A... Stereotactic Bo... | 18 Years - | M.D. Anderson Cancer Center | |
| Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic Cancer | NCT02704143 | Pancreatic Canc... | combination of ... | 18 Years - | Changhai Hospital | |
| Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer | NCT05830838 | Malignant Prost... | Computed Tomogr... Image-Guided Ad... Magnetic Resona... Positron Emissi... Questionnaire A... Stereotactic Bo... | 18 Years - | Mayo Clinic | |
| Safety and Efficacy of SBRT in the Treatment of Thoracic Malignant Tumors at Different Sites | NCT05349552 | Radiotherapy Thoracic Cancer Safety and Effi... | stereotactic bo... | 18 Years - 80 Years | Peking University Third Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
